may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful.
stephen silberstein, md, director, jefferson university headache center..
lawmakers should revisit that idea when lepage is no longer in office next year..
the state launched a review into the newspaper�s findings in late april.